Клиническое наблюдение: пациент 58 лет с резким похуданием, желтухой и кожным зудом

1. Davern T.J. Drug-induced liver disease. Clin Liver Dis 2912; 16:231-45.

2. Leise M.D., Poterucha J.J., Talwalkar J.A. Druginduced liver injury. Mayo Clin Proc 2014; 89(1):95-106.

3. Björnsson E.S. Drug-induced liver injury: an overview over the most critical compounds. Arch Toxicol 2015; 89:327-34.

4. Corsini A., Bortolini M. Drug-induced liver injury: The role of drug metabolism and transport. J Clin Pharmacol 2013; 53(5):463-74.

5. Chalasani N.P., Hayashi P.H., Bonkovsky H.L., Navarro V.J., Lee W.M., Fontana R.J., on behalf of the Practice Parameters Committee of the American College of Gastroenterology. ACG clinical guideline: The diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 2014; 109(7):950-66.

6. Rochon J., Protiva P. , Seeff L.B., Fontana R.J., Liangpunsakul S., Watkins P.B., Davern T., McHutchison J.G. Drug-Induced Liver Injury Network (DILIN). Reliability of the roussel uclaf causality assessment method for assessing causality in drug-induced liver injury. Hepatology 2008; 48:1175-83.

7. Teschke R., Frenzel C., Glass X., Schulze J., Eickhoff A. Greater celandine hepatotoxicity: A clinical review. Ann Hepatol 2012; 11(6):838-48.

8. Teschke R., Glass X., Schulze J., Eickhoff A. Suspected greater celandine hepatotoxicity: Liver-specific causality evaluation of published case reports from Europe. Eur J Gastroenterol Hepatol 2012; 24(3):270-80.

9. Teschke R., Genthner A., Wolff A., Frenzel C., Schulze J., Eickhoff A. Herbal hepatotoxicity: Analysis of cases with initially reported positive re-exposure tests. Dig Liver Dis 2014; 46(3):264-9.

10. Kleiner D.E., Chalasani N.P., Lee W.M., Fontana R.J., Bonkovsky H.L., Watkins P.B., Hayashi P.H., Davern T.J., Navarro V., Reddy R. Talwalkar J.A., Stolz A., Gu J., Barnhart H., Hoofnagle J.H. Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations. Hepatology 2014; 59:661-70.

11. Aleksunes L.M., Slitt A.M., Cherrington N.J., Thibodeau M.S., Klaassen C.D., Manautou J.E. Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride. Toxicol Sci 2005; 83(1):44-52.

12. Aleksunes L.M., Campion S.N., Goedken M.J., Manautou J.E. Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. Toxicol Sci 2008; 104(2):261-73.

13. Деева Т.А., Герман Е.Н., Маевская М.В., Ивашкин В.Т. Алгоритм ведения пациента с острым холестатическим гепатитом (Клиническое наблюдение). Рос журн гастроэнтерол гепатол колопроктол 2011; 21(6):56-63.

14. Alfadda A.A., Sallam R.M., Elawad G.E., AlDhukair H., Alyahya M.M. Subacute thyroiditis: clinical presentation and long term outcome. Int J Endocrinol 2014; 2014:1-7.

15. Carle A., Laurberg P., Pedersen I.B., Knudsen N., Perrild H., Ovesen L., Rasmussen L.B. Jorgensen T. Epidemiology of subtypes of hypothyroidism in Denmark. Eur J Endocrinol 2006; 154:21-8.

16. Sweeney L.B., Stewart C., Gaitonde D.Y. Thyroiditis: An integrated approach. Am Fam Physician 2014; 90(6):389-96.